Sign In

Mark Barrett

Biopharma Executive, Board member, Founder & Entrepreneur

Mark Barrett is a strategic executive leader and board member with over 25 years of experience in the biopharma industry.

He has a proven track record of success in leading organizations, creating companies, building teams, developing drug programs, and driving corporate development.

Mark Barrett has been involved in strategic deals worth over $5B, global co-development programs with 200,000+ patients, and has led the launch of $2B+ revenue products.

His experience spans across North America, Europe, and Asia, with a strong network in biotech, pharma, and venture capital.

Mark Barrett holds a BS in Biology from Duke University, an MBA in Finance from the University of California, Berkeley, Haas School of Business, and has studied at Mount Saint Charles Academy.

He has held key positions at companies like Madrigal Pharmaceuticals, Lassen Therapeutics, Frazier Healthcare Partners, Genzyme (Sanofi), Johnson & Johnson, and Eli Lilly.

Mark Barrett's roles have included Chief Business Officer, Founder, CEO, Board member, Advisor, Head of Strategy & Business Development, VP, and Director in various organizations within the biopharma sector.

His professional journey also includes research roles at ACADIA Pharmaceuticals, Digital Gene Technologies, Harvard Medical School, and Duke University Medical Center.

Highlights

May 24 · linkedin

Great presentation of Phase 1 data for Lassen Therapeutics' first-in-class #IL11 R blocker, LASN01, by James Swaney at #ATS today. Amazing to see the hard work of the entire Lassen team produce exciting data and pave the way to bring this novel therapy to patients in need.

Apr 17 · linkedin

Lassen Therapeutics‘s H. Toni Jun is presenting exciting new data about our industry leading anti-#IL18BP program at #AACR. Blocking #IL18BP is an exciting new approach to stimulate innate and adaptive immune responses to cancer!

Mark Barrett
Add to my network

Location

Cambridge, Massachusetts, United States